PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion- Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)
Abstract
Authors
E. De cock A.M. Carella S. Tao C. Wiesner